Terms: = Pancreatic cancer AND WWTR1, ENSG00000018408, 25937, Q9GZV5, DKFZP586I1419
5 results:
1. Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.
Yang KC; Kalloger SE; Aird JJ; Lee MKC; Rushton C; Mungall KL; Mungall AJ; Gao D; Chow C; Xu J; Karasinska JM; Colborne S; Jones SJM; Schrader J; Morin RD; Loree JM; Marra MA; Renouf DJ; Morin GB; Schaeffer DF; Gorski SM
Cell Rep; 2021 Oct; 37(2):109817. PubMed ID: 34644566
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset.
Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A
Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740
[TBL] [Abstract] [Full Text] [Related]
3. YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy.
Thompson BJ
Bioessays; 2020 May; 42(5):e1900162. PubMed ID: 32128850
[TBL] [Abstract] [Full Text] [Related]
4. Function and cancer genomics of FAT family genes (review).
Katoh M
Int J Oncol; 2012 Dec; 41(6):1913-8. PubMed ID: 23076869
[TBL] [Abstract] [Full Text] [Related]
5. A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.
Balasenthil S; Chen N; Lott ST; Chen J; Carter J; Grizzle WE; Frazier ML; Sen S; Killary AM
Cancer Prev Res (Phila); 2011 Jan; 4(1):137-49. PubMed ID: 21071578
[TBL] [Abstract] [Full Text] [Related]
